Sernova Biotherapeutics Balance Sheet

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Apr '25 Apr 30, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	2016 - 2020
Cash & Equivalents	2	6.01	8.72	3.78	27.87	3.95	Upgrade
Short-Term Investments	-	-	11.08	46	-	-	Upgrade
Cash & Short-Term Investments	2	6.01	19.81	49.78	27.87	3.95	Upgrade
Cash Growth	-76.44%	-69.64%	-60.21%	78.57%	605.78%	3.82%	Upgrade
Other Receivables	0.43	0.3	1.05	1.15	0.45	0.51	Upgrade
Receivables	0.43	0.3	1.05	1.15	0.45	0.51	Upgrade
Prepaid Expenses	0.48	0.16	0.16	0.17	0	0.15	Upgrade
Total Current Assets	2.91	6.47	21.02	51.09	28.33	4.61	Upgrade
Property, Plant & Equipment	0.74	0.83	0.51	0.65	0.56	0.2	Upgrade
Other Intangible Assets	-	-	0.32	0.52	0.72	0.92	Upgrade
Other Long-Term Assets	0.22	0.22	0.26	0.22	0.21	-	Upgrade
Total Assets	3.87	7.53	22.11	52.48	29.82	5.73	Upgrade
Accounts Payable	18.95	17.24	6.85	3.61	0.38	0.53	Upgrade
Accrued Expenses	0.84	2.67	2.51	0.99	0.91	0.35	Upgrade
Current Portion of Leases	0.11	0.1	0.14	0.14	0.12	-	Upgrade
Other Current Liabilities	-	-	0.1	-	0.07	-	Upgrade
Total Current Liabilities	23.32	20.02	9.59	4.74	1.48	0.88	Upgrade
Long-Term Debt	0.81	-	-	-	-	0.7	Upgrade
Long-Term Leases	0.41	0.47	-	0.14	0.28	-	Upgrade
Total Liabilities	24.53	20.48	9.59	4.88	1.75	1.58	Upgrade
Common Stock	118.06	116.68	110.99	110.99	74.01	44.64	Upgrade
Additional Paid-In Capital	20.65	20.69	19.69	12.49	5.11	5.74	Upgrade
Retained Earnings	-159.83	-150.36	-118.17	-79.17	-54.75	-47.78	Upgrade
Comprehensive Income & Other	0.45	0.03	-	3.3	3.69	1.55	Upgrade
Shareholders' Equity	-20.66	-12.96	12.51	47.61	28.07	4.14	Upgrade
Total Liabilities & Equity	3.87	7.53	22.11	52.48	29.82	5.73	Upgrade
Total Debt	4.74	0.57	0.14	0.28	0.39	0.7	Upgrade
Net Cash (Debt)	-2.74	5.44	19.67	49.5	27.48	3.25	Upgrade
Net Cash Growth	-	-72.33%	-60.26%	80.13%	746.40%	-14.65%	Upgrade
Net Cash Per Share	-0.01	0.02	0.06	0.18	0.11	0.02	Upgrade
Filing Date Shares Outstanding	328.48	328.48	303.33	303.33	262.26	231.39	Upgrade
Total Common Shares Outstanding	303.41	325.32	303.33	303.33	261.13	208.26	Upgrade
Working Capital	-20.41	-13.55	11.43	46.35	26.85	3.73	Upgrade
Book Value Per Share	-0.07	-0.04	0.04	0.16	0.11	0.02	Upgrade
Tangible Book Value	-20.66	-12.96	12.2	47.09	27.35	3.23	Upgrade
Tangible Book Value Per Share	-0.07	-0.04	0.04	0.16	0.10	0.02	Upgrade
Machinery	-	0.9	0.9	0.8	0.47	0.45	Upgrade

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.